factual
Credibility built on journal publication and NCCN guidance
The company built credibility by publishing its trial data in major journals like JAMA and by earning a National Comprehensive Cancer Network Category 1 rating, a standard-of-care indication.
factualpending
Speaker
BillEvidence Quote
“We're rated as a NCCN. That's the National Comprehensive Cancer Network. Category 1”
Created: 11/19/2026, 2:27:17 AM
Your notes
Loading notes...